We are live on ! Find out more
CD

Christopher Davis Davis Selected Advisers

AUM $23.3B
1-Year Est. Return 26.95%
 

Christopher Davis is chairman of Davis Advisors, a multi-generational investment firm known for research-intensive equity management. The firm’s strategies often emphasize financials and other businesses where long-term ownership and careful accounting analysis matter. Davis is a frequent public commentator on active management and long-horizon investing.

This Fund
S&P 500
This Quarter Est. Return
+3.91%
1 Year Est. Return
+26.95%
3 Year Est. Return
+93.11%
5 Year Est. Return
+96.73%
10 Year Est. Return
+388.76%
AUM
$22.9B
AUM Growth
-$331M
Cap. Flow
-$1.06B
Cap. Flow %
-4.63%
Top 10 Hldgs %
47.88%
Holding
146
New
5
Increased
59
Reduced
74
Closed
4

Top Sells

Rank Stock Value
1
MON
Monsanto Co
MON
+$550M
2
AMZN icon
Amazon
AMZN
+$169M
3
JPM icon
JPMorgan Chase
JPM
+$152M
4
V icon
Visa
V
+$95.4M
5
UNH icon
UnitedHealth
UNH
+$66.7M

Sector Composition

Rank Sector Weight
1 Financials 38.79%
2 Consumer Discretionary 13.4%
3 Communication Services 12.27%
4 Energy 10.41%
5 Industrials 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRNO icon
76
Terreno Realty
TRNO
$7.43B
$21.8M 0.1%
646,739
-176,584
-21% -$5.59M
PSA icon
77
Public Storage
PSA
$60.2B
$21.7M 0.1%
104,173
-144
-0.1% -$31K
MAA icon
78
Mid-America Apartment Communities
MAA
$15.2B
$21.5M 0.09%
204,265
+383
+0.2% +$39.4K
ESS icon
79
Essex Property Trust
ESS
$18.6B
$21.4M 0.09%
83,136
-115
-0.1% -$28.9K
QUOT
80
DELISTED
Quotient Technology Inc
QUOT
$20.8M 0.09%
1,809,532
+6,897
+0.4% +$76K
LEXEA
81
DELISTED
Liberty Expedia Holdings, Inc. Class A Common Stock
LEXEA
$19.9M 0.09%
368,920
-39,980
-10% -$2.02M
WELL icon
82
Welltower
WELL
$172B
$18.9M 0.08%
252,893
+847
+0.3% +$61.9K
CONE
83
DELISTED
CyrusOne Inc Common Stock
CONE
$18.4M 0.08%
330,205
-50
-0% -$2.76K
ACC
84
DELISTED
American Campus Communities, Inc.
ACC
$16.2M 0.07%
342,954
+783
+0.2% +$37.2K
VNO icon
85
Vornado Realty Trust
VNO
$7.07B
$15.6M 0.07%
205,537
-10
-0% -$775
PLD icon
86
Prologis
PLD
$135B
$15.5M 0.07%
263,950
-107,334
-29% -$5.98M
BIDU icon
87
Baidu
BIDU
$31.6B
$15.4M 0.07%
86,105
+3,242
+4% +$587K
SAP icon
88
SAP
SAP
$252B
$14.8M 0.06%
141,379
+4,409
+3% +$455K
DGX icon
89
Quest Diagnostics
DGX
$27B
$14.7M 0.06%
132,589
+3,170
+2% +$335K
GGP
90
DELISTED
GGP Inc.
GGP
$14.7M 0.06%
624,251
+255,814
+69% +$5.89M
VMRK
91
Vivmark Residential
VMRK
$25B
$14.6M 0.06%
221,877
+510
+0.2% +$33.3K
CCI icon
92
Crown Castle
CCI
$32.1B
$14.2M 0.06%
142,060
-65
-0% -$6.39K
VSA
93
VisionSys AI
VSA
$9.78M
$14.2M 0.06%
+317
New +$14.7M
FR icon
94
First Industrial Realty Trust
FR
$8.34B
$13.9M 0.06%
485,582
+1
+0% +$29
AKR icon
95
Acadia Realty Trust
AKR
$2.89B
$13.8M 0.06%
498,160
-851
-0.2% -$24.4K
WY icon
96
Weyerhaeuser
WY
$17.6B
$13.3M 0.06%
398,204
-48
-0% -$1.62K
ROIC
97
DELISTED
Retail Opportunity Investments Corp.
ROIC
$12.4M 0.05%
648,444
-77
-0% -$1.57K
ARE icon
98
Alexandria Real Estate Equities
ARE
$9.21B
$11.8M 0.05%
97,540
-8
-0% -$931
DCT
99
DELISTED
DCT Industrial Trust Inc.
DCT
$11.7M 0.05%
218,145
+1,062
+0.5% +$55.4K
REG icon
100
Regency Centers
REG
$13.9B
$11.3M 0.05%
181,067
+95,231
+111% +$6.01M

Similar funds

Christopher Davis's Q2 2017 Portfolio in Review

As of Q2 2017, Christopher Davis held 146 positions worth $22.9B, down 1.4% from $23.2B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Christopher Davis withdrew a net $1.06B in Q2 2017, closing 4 positions and reducing 74 holdings. Its most notable exit was Bausch Health, an estimated $43.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 39% of assets, up from 37% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Christopher Davis opened a new position in Alleghany Corp worth $46.4M.

  • Christopher Davis's largest Q2 2017 buy was Alleghany Corp: 77,974 shares worth $46.4M.
  • Christopher Davis added most to Capital One in Q2 2017, an estimated $347M increase.
  • Christopher Davis's biggest Q2 2017 reduction was Monsanto Co, cutting an estimated $550M.
  • Christopher Davis fully exited Bausch Health in Q2 2017, selling an estimated $43.2M.
  • Christopher Davis's ten largest holdings make up 48% of its $22.9B portfolio in Q2 2017.
  • Christopher Davis opened 5 new positions and closed 4 in Q2 2017.
  • Christopher Davis's portfolio value fell 1.4% quarter-over-quarter to $22.9B.

Based on Davis Selected Advisers's 13F filing for Q2 2017, filed 9 Aug 2017.